Axonics, Inc. v. Medtronic, Inc.
Docket No. 2022-1451, -1452 (IPR2020-00715, -00679) (https://cafc.uscourts.gov/opinions-orders/22-1451.OPINION.7-10-2023_2154482.pdf)
LOURIE, DYK, TARANTO
July 10, 2023
Brief Summary: Board IPR decision finding Axonics did not show Medtronic’s patents to be obvious reverses as based on incorrect narrowing of the prior art.
Summary: Axonics timely appealed IPR final written decisions in which the Board found it had not shown Medtronic’s claims (of US 8,626,314 and 8,036,756) directed to implantable nerve stimulation systems obvious. The claims include “features key to the present appeal: at least two electrodes at the distal end of the lead, with ‘a plurality
Continue Reading Board IPR decisions of no obviousness vacated and remanded for erroneous motivation to combine analysis